Loraz and Torecan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Torecan (thiethylperazine maleate). Common drug interactions include feeling hot among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Torecan. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Torecan?

Torecan has active ingredients of thiethylperazine maleate. eHealthMe is studying from 406 Torecan users. Check the latest studies of Torecan.



On Jul, 10, 2026

18 people who take Loraz and Torecan together, and have interactions are studied.

Loraz and Torecan drug interactions.

What are the common drug interactions of Loraz and Torecan, by gender? *:

female:

  1. Feeling hot
  2. Chest discomfort
  3. Dyspnoea (difficult or laboured respiration)
  4. Pruritus generalised (generalized itching)
  5. Acute myocardial infarction (acute heart attack)
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Bile duct cancer
  9. Blood alkaline phosphatase increased
  10. Blood pressure diastolic decreased

male:

  1. Anaemia (lack of blood)
  2. Blood potassium decreased
  3. Rectal haemorrhage (bleeding from anus)
  4. Vomiting
  5. White blood cell count decreased
  6. Abdominal pain
  7. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Blood calcium decreased
  10. Cardiac failure congestive

What are the common drug interactions of Loraz and Torecan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Acute myocardial infarction (acute heart attack)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Bile duct cancer
  5. Blood alkaline phosphatase increased
  6. Chills (felling of cold)
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Disease progression
  9. Electrocardiogram t wave inversion
  10. Feeling hot

40-49:

  1. Chest discomfort
  2. Dyspnoea (difficult or laboured respiration)
  3. Feeling hot
  4. Pruritus generalised (generalized itching)

50-59:

  1. Blood potassium decreased
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Haemoglobin decreased
  5. Platelet count decreased
  6. Pyrexia (fever)
  7. White blood cell count decreased
  8. Abdominal pain
  9. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  10. Blood calcium decreased

60+:

  1. Anaemia (lack of blood)
  2. Cholecystitis (infection of gallbladder)
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea haemorrhagic (bloody diarrhoea)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Hypokalaemia (low potassium)
  7. Ileal ulcer
  8. International normalised ratio increased
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Proctitis (inflammation of the rectum and anus)

What are the existing conditions these people have? *

  1. Prostate Cancer: 1 person, 5.56%
  2. Pain: 1 person, 5.56%
  3. Ovarian Cancer (cancer of ovary): 1 person, 5.56%
  4. Osteoporosis (bones weak and more likely to break): 1 person, 5.56%
  5. Metastases To Bone (cancer spreads to bone): 1 person, 5.56%
  6. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.56%
  7. Dizziness: 1 person, 5.56%
  8. Depression: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Torecan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Torecan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Torecan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Torecan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and thiethylperazine maleate (the active ingredients of Loraz and Torecan, respectively), and Loraz and Torecan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: